Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 22, Issue 3-4
October 2023
Neurodegenerative Diseases Cover Image for Volume 22, Issue 3-4
All Issues
ISSN 1660-2854
EISSN 1660-2862

Neurodegenerative Diseases 2022, Vol. 22, No. 3-4

Publisher's Note

New editorship of Neurodegenerative Diseases
Neurodegener Dis (2022) 22 (3-4): 87. https://doi.org/10.1159/000531607
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Editorial

A Pivotal Time
Gilles Allali
Neurodegener Dis (2022) 22 (3-4): 88–90. https://doi.org/10.1159/000531867
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Review Article

The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-19
Giulia Bommarito; Valentina Garibotto; Giovanni B Frisoni; Frédéric Assal; Patrice H Lalive; Gilles Allali
Neurodegener Dis (2022) 22 (3-4): 91–103. https://doi.org/10.1159/000530566
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Research Article

Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival
Robert J. Nona; Zhouwei Xu; Gail A. Robinson; Robert D. Henderson; Pamela A. McCombe
Neurodegener Dis (2022) 22 (3-4): 104–121. https://doi.org/10.1159/000528875
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: DFTs, 3D-QSAR, ADMET, and Molecular Dynamics Simulation
Syeda Abida Ejaz; Ammara Fayyaz; Hafiz Mohammad Kashif Mahmood; Mubashir Aziz; Syeda Rabia Ejaz; Afrah Fahad Alkhuriji; Wafa Abdullah I. Al-Megrin; Abdullahi Tunde Aborode; Gaber El-Saber Batiha
Neurodegener Dis (2022) 22 (3-4): 122–138. https://doi.org/10.1159/000527516
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Clinical Manifestations Associated with the Domain-Containing Protein 2 Gene Mutation in an Iranian Family with Spastic Paraplegia 54
Abolfazl Yari; Shokoofeh Etesam; Shannaz Zarifi; Sepideh Parvizpour; Ebrahim Miri-Moghaddam
Neurodegener Dis (2022) 22 (3-4): 139–150. https://doi.org/10.1159/000530375
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer’s Disease
Jesús Garcia Castro; Helena Méndez del Sol; Olaia Rodríguez Fraga; María Hernández Barral; Soledad Serrano López; Ana Frank García; Ángel Martín Montes
Neurodegener Dis (2022) 22 (3-4): 151–158. https://doi.org/10.1159/000530907
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Brief Report

Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients: Ecological validity of the MoCA in PD
Edoardo Nicolò Aiello; Alfonsina D’Iorio; Federica Solca; Silvia Torre; Eleonora Colombo; Alessio Maranzano; Alberto De Lorenzo; Valerio Patisso; Mauro Treddenti; Claudia Morelli; Alberto Doretti; Luca Maderna; Federico Verde; Roberta Ferrucci; Sergio Barbieri; Fabiana Ruggiero; Alberto Priori; Vincenzo Silani; Nicola Ticozzi; Gabriella Santangelo; Andrea Ciammola; Barbara Poletti
Neurodegener Dis (2022) 22 (3-4): 159–163. https://doi.org/10.1159/000532115
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Acknowledgement to Reviewers
Neurodegener Dis (2022) 22 (3-4): 164. https://doi.org/10.1159/000534161
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Contents Vol. 22, 2022
Neurodegener Dis (2022) 22 (3-4): I–IV. https://doi.org/10.1159/000534159
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Anti-amyloid monoclonal antibodies for the treatment of Alzheimer disease: Intersocietal recommendations for their appropriate use in Switzerland
Anti-amyloid treatments, a therapeutic revolution, ready for Europe
Alzheimer's disease, β-amyloid peptides and ubiquitin-proteasome system: nutritherapeutic insights
Contents Vol. 24, 2024
  • Online ISSN 1660-2862
  • Print ISSN 1660-2854
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal